Kelly Financial Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $390K | Sell |
1,549
-1
| -0.1% | -$215 | 0.08% | 87 |
|
|
2026
Q1 | $337K | Sell |
1,550
-68
| -4% | -$15.1K | 0.08% | 89 |
|
|
2025
Q4 | $370K | Sell |
1,618
-276
| -15% | -$62.9K | 0.09% | 75 |
|
|
2025
Q3 | $439K | Buy |
1,894
+87
| +5% | +$17.7K | 0.11% | 68 |
|
|
2025
Q2 | $335K | Buy |
1,807
+166
| +10% | +$30.9K | 0.1% | 79 |
|
|
2025
Q1 | $344K | Buy |
1,641
+144
| +10% | +$28K | 0.12% | 74 |
|
|
2024
Q4 | $266K | Buy |
1,497
+104
| +7% | +$19.1K | 0.1% | 94 |
|
|
2024
Q3 | $275K | Buy |
1,393
+76
| +6% | +$14.2K | 0.1% | 90 |
|
|
2024
Q2 | $226K | Buy |
1,317
+446
| +51% | +$73.9K | 0.08% | 100 |
|
|
2024
Q1 | $159K | Buy |
871
+69
| +9% | +$11.9K | 0.06% | 122 |
|
|
2023
Q4 | $124K | Buy |
802
+146
| +22% | +$21.3K | 0.05% | 124 |
|
|
2023
Q3 | $97.8K | Sell |
656
-37
| -5% | -$5.43K | 0.04% | 125 |
|
|
2023
Q2 | $93.3K | Buy |
693
+218
| +46% | +$32K | 0.04% | 128 |
|
|
2023
Q1 | $75.7K | Buy |
475
+91
| +24% | +$13.9K | 0.04% | 142 |
|
|
2022
Q4 | $62K | Buy |
384
+3
| +0.8% | +$460 | 0.03% | 152 |
|
|
2022
Q3 | $51.2K | Buy |
381
+2
| +0.5% | +$287 | 0.03% | 152 |
|
|
2022
Q2 | $58K | Buy |
379
+3
| +0.8% | +$458 | 0.03% | 147 |
|
|
2022
Q1 | $61K | Buy |
376
+2
| +0.5% | +$291 | 0.03% | 157 |
|
|
2021
Q4 | $50.6K | Buy |
374
+3
| +0.8% | +$354 | 0.02% | 173 |
|
|
2021
Q3 | $40K | Buy |
371
+2
| +0.5% | +$229 | 0.02% | 183 |
|
|
2021
Q2 | $41.5K | Buy |
369
+3
| +0.8% | +$338 | 0.02% | 183 |
|
|
2021
Q1 | $39.6K | Buy |
366
+13
| +4% | +$1.39K | 0.02% | 150 |
|
|
2020
Q4 | $37.9K | Buy |
353
+3
| +0.9% | +$288 | 0.03% | 138 |
|
|
2020
Q3 | $30.7K | Sell |
350
-100
| -22% | -$9.41K | 0.02% | 134 |
|
|
2020
Q2 | $44.1K | Buy |
450
+24
| +6% | +$2.11K | 0.03% | 99 |
|
|
2020
Q1 | $32.4K | Buy |
426
+91
| +27% | +$7.75K | 0.04% | 105 |
|
|
2019
Q4 | $29.7K | Hold |
335
| – | – | 0.02% | 124 |
|
|
2019
Q3 | $25.4K | Sell |
335
-75
| -18% | -$5.14K | 0.02% | 131 |
|
|
2019
Q2 | $29.8K | Buy |
410
+10
| +3% | +$786 | 0.03% | 121 |
|
|
2019
Q1 | $32.2K | Buy |
+400
| New | +$32.7K | 0.04% | 113 |
|
Other funds holding ABBV
Kelly Financial Services's ABBV Position: Q2 2026 in Review
Kelly Financial Services reduced its AbbVie (ABBV) stake by 0.06% in Q2 2026, selling an estimated $215 and leaving 1,549 shares worth $390K. The position accounts for 0.08% of the portfolio, ranked #87.
Kelly Financial Services first reported a position in ABBV in Q1 2019 and has held it in 30 quarters since. The position peaked at $439K in Q3 2025. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Kelly Financial Services held 1,549 shares of AbbVie worth $390K as of Q2 2026.
- Kelly Financial Services sold 1 AbbVie share in Q2 2026, an estimated $215.
- AbbVie made up 0.08% of Kelly Financial Services's portfolio in Q2 2026, its #87 holding.
- Kelly Financial Services first reported a position in AbbVie in Q1 2019 and has held it in 30 quarters since.
- Kelly Financial Services's AbbVie position peaked at $439K in Q3 2025.
- 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Kelly Financial Services's 13F filing for Q2 2026, filed 14 Jul 2026.